Wegovy Pills Cost and Current Pricing
Wegovy pills cost varies significantly based on dosage, pharmacy, and location, with a typical monthly supply of 2.4 mg semaglutide tablets priced between $1,300 and $1,600 without insurance. The manufacturer, Novo Nordisk, sets the list price for the oral formulation, which was approved by the FDA in 2019 as a weight management treatment for adults with obesity or overweight conditions. Prices at major pharmacy chains such as CVS, Walgreens, and Walmart may differ, and discount programs or manufacturer coupons can reduce the out-of-pocket expense for eligible patients. For a detailed breakdown of the current Wegovy pills cost, you can check the official Novo Nordisk patient resources here.
The Wegovy pills cost for a 30-day supply at the maintenance dose of 2.4 mg generally falls in the range of $1,300 to $1,600, though this can fluctuate based on the pharmacy and region. The oral semaglutide formulation is taken once daily, and the Wegovy pills cost may be higher at the start of treatment when patients are on the lower dosage titration steps before reaching the maintenance dose. Some online pharmacy platforms and discount services offer lower prices, but consumers should verify the legitimacy of these sources to ensure medication safety and authenticity.
Insurance Coverage and Wegovy Pills Cost
Insurance coverage for Wegovy varies widely, and many commercial health plans now include semaglutide under their prescription drug benefits, which can lower the Wegovy pills cost to a copay of $25 to $150 per month. Medicare Part D and Medicaid coverage for Wegovy is limited and subject to specific medical necessity criteria, meaning the Wegovy pills cost for Medicare beneficiaries is often the full list price unless they qualify for extra help or a manufacturer savings program. Patients should contact their insurance provider directly to confirm formulary status and any prior authorization requirements that affect their Wegovy pills cost.
Even with insurance, the Wegovy pills cost can remain high if the plan imposes a coverage gap or if the patient reaches their annual out-of-pocket maximum late in the year. Novo Nordisk offers a savings card program for commercially insured patients, which can reduce the Wegovy pills cost to as low as $25 per month for eligible individuals, but this card is not valid for patients covered by government-funded programs such as Medicare or Medicaid. The savings card terms and eligibility are detailed on the Novo Nordisk savings website here.
Comparing Wegovy Pills Cost to Other Weight Loss Medications
When compared to other GLP-1 receptor agonist medications, the Wegovy pills cost is generally higher than the injectable Wegovy formulation and significantly higher than older generic weight loss drugs such as phentermine-topiramate. The Wegovy pills cost reflects the convenience of a daily oral dose, which some patients prefer over weekly injections, but the price difference can be a barrier for those without comprehensive insurance coverage. A direct comparison of the Wegovy pills cost versus the injectable semaglutide formulation shows that the oral version is priced at a premium, though both contain the same active ingredient at the therapeutic dose.
Alternative weight loss medications such as Qsymia, Contrave, and the injectable Wegovy have different pricing structures, and the Wegovy pills cost may be more accessible through specific insurance plans that favor oral formulations. The Wegovy pills cost also compares differently to compounded semaglutide options, which are not FDA-approved and may offer lower prices but carry risks regarding quality and efficacy. Patients evaluating the Wegovy pills cost should discuss all available options with their healthcare provider to balance effectiveness, safety, and affordability based on their individual treatment goals.